The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity

NCT07271771 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Denosumab
DRUG: Saline (0.9% NaCl)

Sponsor

Aarhus University Hospital

Collaborators

[object Object]